Skip to main content
PMC home page
The Journal of Hygiene logoLink to The Journal of Hygiene
. 1973 Sep;71(3):433–445. doi: 10.1017/s0022172400046416

The sequential appearance of antibody and immunoglobins in nasal secretion after immunization of volunteers with live and inactivated influenza B virus vaccines

Jean C Downie
PMCID: PMC2130575  PMID: 4518342

Abstract

The sequential development of the immune response in nasal washings was studied in 54 volunteers immunized with either attenuated or inactivated influenza B/Eng/13/65 virus vaccines.

Eleven of the 15 volunteers given the inactivated vaccine by deep subcutaneous inoculation showed no rise in nasal wash protein or immunoglobins due to the immunization procedure nor was specific neutralizing antibody detected in their nasal washings after immunization. Neutralizing antibody was detected in nasal washings of three volunteers in this group who also showed a 20-fold or greater increase in serum haemagglutinin-inhibiting antibody after immunization and in one volunteer who had antibody present in pre-trial nasal washings.

Eleven of 15 volunteers who were successfully infected by the live attenuated vaccine showed a characteristic rise in protein and IgA and IgG immunoglobin concentrations in nasal washings 5-14 days after the administration of the live virus vaccine. Neutralizing antibody was detected in the nasal washings of these 11 volunteers and appeared at the same time as or 1-2 days after the initial rise of protein and immunoglobin. Neutralizing antibody was also detected in the nasal washings of one other volunteer who did not show a rise in protein or immunoglobin concentration in nasal washings after immunization.

IgA was detected (≥ 3 mg./100 ml.) in the majority (84%) of nasal wash specimens which had a protein concentration of 0·2 mg./ml. or greater while IgG was not detected (≥ 4·5 mg./100 ml.) until the protein concentration rose to 0·4 mg./ml. or greater. The geometric mean concentration for normal nasal wash protein in this study was 0·3 ± 0·1 mg./ml.

Regression analysis indicated that the concentrations of both IgA and IgG immunoglobins were directly proportional to the protein concentration in nasal washings but that this relationship varied considerably between individuals.

Absorption studies indicated that neutralizing and haemagglutinin-inhibiting antibodies in nasal secretion to influenza B/Eng/13/65 virus were predominantly associated with the IgA class of immunoglobin.

Full text

PDF
433

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARTENSTEIN M. S., BELLANTI J. A., BUESCHER E. L. IDENTIFICATION OF THE ANTIVIRAL SUBSTANCES IN NASAL SECRETIONS. Proc Soc Exp Biol Med. 1964 Nov;117:558–564. doi: 10.3181/00379727-117-29637. [DOI] [PubMed] [Google Scholar]
  2. Alford R. H., Rossen R. D., Butler W. T., Kasel J. A. Neutralizing and hemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus. J Immunol. 1967 Apr;98(4):724–731. [PubMed] [Google Scholar]
  3. BELLANTI J. A., ARTENSTEIN M. S., BUESCHER E. L. CHARACTERIZATION OF VIRUS NEUTRALIZING ANTIBODIES IN HUMAN SERUM AND NASAL SECRETIONS. J Immunol. 1965 Mar;94:344–351. [PubMed] [Google Scholar]
  4. Beare A. S., Bynoe M. L., Tyrrell D. A. Investigetion into the attenuation of influenza viruses by serial passage. Br Med J. 1968 Nov 23;4(5629):482–484. doi: 10.1136/bmj.4.5629.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Butler W. T., Rossen R. D., Waldmann T. A. The mechanism of appearance of immunoglobulin A in nasal secretions in man. J Clin Invest. 1967 Dec;46(12):1883–1893. doi: 10.1172/JCI105678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Butler W. T., Waldmann T. A., Rossen R. D., Douglas R. G., Jr, Couch R. B. Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man. J Immunol. 1970 Sep;105(3):584–591. [PubMed] [Google Scholar]
  7. Downie J. C. Neuraminidase- and hemagglutinin-inhibiting antibodies in serum and nasal secretions of volunteers immunized with attenuated and inactivated influenza B-Eng-13-65 virus vaccines. J Immunol. 1970 Sep;105(3):620–626. [PubMed] [Google Scholar]
  8. Downie J. C., Stuart-Harris C. H. The production of neutralizing activity in serum and nasal secretion following immunization with influenza B virus. J Hyg (Lond) 1970 Jun;68(2):233–244. doi: 10.1017/s0022172400028709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fazekas de St Groth, Webster R. G. Disquisitions of Original Antigenic Sin. I. Evidence in man. J Exp Med. 1966 Sep 1;124(3):331–345. doi: 10.1084/jem.124.3.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Finter N. B. Quantitative hemadsorption, a new assay technique. II. Assay of neutralizing antibodies to hemadsorbing viruses. J Immunol. 1967 Jan;98(1):88–93. [PubMed] [Google Scholar]
  11. Fulk R. V., Fedson D. S., Huber M. A., Fitzpatrick J. R., Kasel J. A. Antibody responses in serum and nasal secretions according to age of recipient and method of administration of A2-Hong Kong-68 inactivated influenza virus vaccine. J Immunol. 1970 Jan;104(1):8–13. [PubMed] [Google Scholar]
  12. Kasel J. A., Hume E. B., Fulk R. V., Togo Y., Huber M., Hornick R. B. Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine. J Immunol. 1969 Mar;102(3):555–562. [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  15. Mann J. J., Waldman R. H., Togo Y., Heiner G. G., Dawkins A. T., Kasel J. A. Antibody response in respiratory secretions of volunteers given live and dead influenza virus. J Immunol. 1968 Apr;100(4):726–735. [PubMed] [Google Scholar]
  16. Mostow S. R., Schoenbaum S. C., Dowdle W. R., Coleman M. T., Kaye H. S., Hierholzer J. C. Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man. Am J Epidemiol. 1970 Oct;92(4):248–256. doi: 10.1093/oxfordjournals.aje.a121204. [DOI] [PubMed] [Google Scholar]
  17. REMINGTON J. S., VOSTI K. L., LIETZE A., ZIMMERMAN A. L. SERUM PROTEINS AND ANTIBODY ACTIVITY IN HUMAN NASAL SECRETIONS. J Clin Invest. 1964 Aug;43:1613–1624. doi: 10.1172/JCI105037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rossen R. D., Butler W. T., Cate T. R., Szwed C. F., Couch R. B. Protein composition of nasal secretion during respiratory virus infection. Proc Soc Exp Biol Med. 1965 Aug-Sep;119(4):1169–1176. doi: 10.3181/00379727-119-30406. [DOI] [PubMed] [Google Scholar]
  19. Rossen R. D., Butler W. T., Waldman R. H., Alford R. H., Hornick R. B., Togo Y., Kasel J. A. The proteins in nasal secretion. II. A longitudinal study of IgA and neutralizing antibody levels in nasal washings from men infected with influenza virus. JAMA. 1970 Feb 16;211(7):1157–1161. doi: 10.1001/jama.211.7.1157. [DOI] [PubMed] [Google Scholar]
  20. Rossen R. D., Morgan C., Hsu K. C., Butler W. T., Rose H. M. Localization of 11 S external secretory IgA by immunofluorescence in tissues lining the oral and respiratory passages in man. J Immunol. 1968 Apr;100(4):706–717. [PubMed] [Google Scholar]
  21. Rossen R. D., Schade A. L., Butler W. T., Kasel J. A. The proteins in nasal secretion: a longitudinal study of the gammaA-globulin, gammaG-globulin, albumin, siderophilin, and total protein concentrations in nasal washings from adult male volunteers. J Clin Invest. 1966 May;45(5):768–776. doi: 10.1172/JCI105391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Smith C. B., Purcell R. H., Bellanti J. A., Chanock R. M. Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med. 1966 Nov 24;275(21):1145–1152. doi: 10.1056/NEJM196611242752101. [DOI] [PubMed] [Google Scholar]
  23. South M. A., Cooper M. D., Wollheim F. A., Hong R., Good R. A. The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva. J Exp Med. 1966 Apr 1;123(4):615–627. doi: 10.1084/jem.123.4.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. TOMASI T. B., Jr, TAN E. M., SOLOMON A., PRENDERGAST R. A. CHARACTERISTICS OF AN IMMUNE SYSTEM COMMON TO CERTAIN EXTERNAL SECRETIONS. J Exp Med. 1965 Jan 1;121:101–124. doi: 10.1084/jem.121.1.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Waldman R. H., Mann J. J., Kasel J. A. Influenza virus neutralizing antibody in human respiratory secretions. J Immunol. 1968 Jan;100(1):80–85. [PubMed] [Google Scholar]

Articles from The Journal of Hygiene are provided here courtesy of Cambridge University Press

RESOURCES